ADORA2A and depressive symptom measurement: Thus, the selective manipulation of presynaptic A2AR in glutamatergic terminals [43] may have a therapeutic value to manage a variety of neuropsychiatric behaviors such as anxiety, depression, psychosis and schizophrenia [44].